Executive summary * The UK National Institute for Health and Care Excellence (guideline setting organisation) has approved a PCSK9 inhibitor called inclisiran, which is administered by injection twice a year. * The list price is approximately ... [Continue Reading]
Aspirin & cancer survival
Executive summary * Low dose aspirin has been the subject of much research in the fields of cancer and cardiovascular disease. It has been studied for potential prevention and help post diagnosis. * This week's note examines a very large ... [Continue Reading]
‘Fast’ & ‘slow’ carbs
Executive summary * A study has just been published, which claimed to have definitively demonstrated that 'fast' carbs do not make you fat. The paper was about the glycemic index (GI), which is a flawed and imprecise measure. 'Fast' carbs are ... [Continue Reading]